New Zealand

Access & coverage

Tax-funded + private optional

Public system + Pharmac drug agency; private optional

Treatment

• Specialist centers for rare / congenital conditions
• Supportive and palliative care when curative options are limited
• Case management across social and medical services

Prevention

• Antenatal care; newborn screening where relevant
• Public-health programs aimed at the specific residual causes
• Social supports that reduce vulnerability

Lifestyle

• Cause-specific advice via primary care
• Family education for congenital / neonatal survivors
• Avoidance of known toxins / teratogens

What stands out here

Same broad other toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.